Although fatty livers are typically associated with insulin resistance [40], the metabolic benefit conferred by skeletal Pgrmc1 loss outweighed the potential disadvantage from hepatic Pgrmc1 loss, thereby ameliorating systemic insulin resistance in T2D PKO mice (Figure S8). Here, PGRMC1 is linked to Insulin resistance.